Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Apollo Neuroscience is a wellness and health technology company that develops and commercializes the Apollo wearable, a non-invasive therapeutic device designed to improve stress resilience, sleep, focus, and cognitive performance. Developed by physicians and neuroscientists at the University of Pittsburgh, the wearable delivers gentle, scientifically validated vibration patterns (touch therapy) that stimulate the vagus nerve and signal safety to the brain. This process helps rebalance the autonomic nervous system and improve heart rate variability (HRV) without requiring active effort from the user. The company's products are backed by multiple clinical trials and are marketed directly to consumers and through corporate wellness programs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Apollo Neurosciences.